BLASTOCYSTIS HOMINIS--STRUCTURE, PHYSIOLOGY AND PATHOGENICITY

过去16年的研究将人芽囊原虫重新归类为 原生动物，将其从酵母菌中移除，在那里它已经挣扎了70年 好几年了。人芽孢杆菌现在被牢固地确立为孢子虫的一员， 肠道寄生虫人类和灵长类动物的肠道寄生虫和病原体。 当人芽孢杆菌大量出现在粪便内容物中时，标记为 腹泻通常是有经验的。选择的药物是甲硝唑。 严重感染的患者已经在临床中心接受了治疗。 有一例死亡病例。 这种原生动物现在是国家和国际关注的主题 寄生虫学家和内科医生将其视为人类腹泻的病程。治疗 通常是用甲硝唑。甲氧苄氨嘧啶-磺胺甲恶唑也被使用 成功了。 人芽胞杆菌有丝分裂症的研究进展缓慢，但我们在 最后，有足够的数据可供发表。 我们每周都会接到来自美国各地的数次电话， 提出囊胚诊断和治疗中存在的问题。

Work over the past sixteen years has reclassified Blastocystis hominis as a protozoan, removing it from the yeasts where it has languished for seventy years. B. hominis is now firmly established as a member of the Sporozoa, an intestinal parasite and pathogen of man and primates. When B. hominis is present in large numbers in stool contents, marked diarrhea is usually experienced. The drug of choice is metronidazole. Patients with severe infection have been treated at the Clinical Center. There was one fatal case. This protozoan is now a subject of national and international interest to parasitologists and physicians as a course of diarrhea in man. Treatment is usually with metronidazole. Trimethoprim-sulfamethoxazole is also used successfully. Progress has been slow on research into B. hominis mitochrondria, but we at last have sufficient data for publication. We receive calls from around the United States a number of times each week, to present problems in diagnosis and treatment of blastocystis.